{"Abstract": "This review provides an update on the current standards of care for adult transgender individuals, focusing on gender-affirming hormone treatment (GAHT). The Endocrine Society 2017 treatment guidelines are highlighted, emphasizing the importance of individualized care plans for both transfeminine and transmasculine patients. Key considerations include the timing of initiation, dosing regimens, and monitoring of hormone levels and potential side effects. The review also addresses the psychological and social aspects of GAHT, underscoring the need for multidisciplinary support to optimize health outcomes and quality of life."}